Patents by Inventor Martin EICHMANN

Martin EICHMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proinsulin peptides for Type 1 Diabetes
    Patent number: 12643934
    Abstract: Disclosed herein is a peptide that can be used in the therapy or prevention of Type 1 Diabetes (T1D), particularly in a patient with a DR3-DQ2 haplotype, as well as methods of diagnosing or determining treatment efficacy, methods of identifying T1D-relevant antigen drivers, and to methods of identifying subjects as being at high-risk of T1D and patients as being suitable for and/or responsive to T1D treatment.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: June 2, 2026
    Assignee: King's College London
    Inventors: Mark Peakman, Johan Verhagen, Martin Eichmann
  • Proinsulin Peptides for Type I Diabetes
    Publication number: 20230348562
    Abstract: The invention relates to a peptide. The peptide can be used in the therapy or prevention of Type 1 Diabetes (T1D), particularly in a patient with a DR3-DQ2 haplotype. The invention also relates to a method of diagnosing or determining treatment efficacy, the method utilising the peptide, as well as to a method of identifying T1D-relevant antigen drivers, methods of identifying subjects as being at high-risk of T1D and patients as being suitable for and/or responsive to T1D treatment.
    Type: Application
    Filed: September 16, 2020
    Publication date: November 2, 2023
    Applicant: King's College London
    Inventors: Mark PEAKMAN, Johan VERHAGEN, Martin EICHMANN